Pharmacology · Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics)

Ivabradine reduces heart rate in stable angina by:

  • A Blocking L-type calcium channels in sinoatrial and AV node
  • B Stimulating cardiac muscarinic M2 receptors
  • C Selectively inhibiting the funny (If) current in sinoatrial node pacemaker cells
  • D Non-selective β-adrenergic receptor blockade
Correct answer: C. Selectively inhibiting the funny (If) current in sinoatrial node pacemaker cells

Explanation

Ivabradine specifically blocks the HCN channel responsible for the hyperpolarisation-activated mixed cation current (If) in sinoatrial pacemaker cells. This current drives spontaneous depolarisation; its inhibition slows the rate of phase 4 depolarisation without affecting contractility, conduction, or blood pressure. Unlike verapamil (L-type Ca2+ blocker), ivabradine has no negative inotropic effect.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs

See all Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs →